← Browse by Condition
Medical Condition
multiple myeloma refractory
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 1, Phase 2, Phase 4
NCT07477912 Phase 1, Phase 2
Recruiting
Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma
Enrollment
30 pts
Location
Belarus
Sponsor
Minsk Scientific-Practical Cen...
NCT07248176
Recruiting
Universal CAR-T Cell Therapy for MM
Enrollment
6 pts
Location
China
Sponsor
Bioray Laboratories
NCT07094048 Phase 4
Recruiting
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Enrollment
80 pts
Location
Canada
Sponsor
CHU de Quebec-Universite Laval